{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:01:24Z","timestamp":1794060084000,"version":"4.8.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T00:00:00Z","timestamp":1601251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"DOI":"10.1038\/s43018-020-00115-2","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T16:05:06Z","timestamp":1601309106000},"page":"998-1009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Metabolic adaptation of acute lymphoblastic leukemia to the central nervous system microenvironment depends on stearoyl-CoA desaturase"],"prefix":"10.1038","volume":"1","author":[{"given":"Angela Maria","family":"Savino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Isabel","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orianne","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zemlyansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1516-2515","authenticated-orcid":false,"given":"Antony","family":"Cousins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke K.","family":"Markert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shani","family":"Barel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifat","family":"Geron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liron","family":"Frishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehudit","family":"Birger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0557-3153","authenticated-orcid":false,"given":"Sergey","family":"Tumanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"MacKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurre J.","family":"Kamphorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7439-292X","authenticated-orcid":false,"given":"Pawel","family":"Herzyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonatan","family":"Fern\u00e1ndez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifat","family":"Abramovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4564-9690","authenticated-orcid":false,"given":"Inbal","family":"Mor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Bardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersilia","family":"Barin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Janaki-Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin R.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Kharas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9770-0956","authenticated-orcid":false,"given":"Eyal","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6938-2540","authenticated-orcid":false,"given":"Shai","family":"Izraeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5449-5246","authenticated-orcid":false,"given":"Christina","family":"Halsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,28]]},"reference":[{"key":"115_CR1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","volume":"11","author":"RA Cairns","year":"2011","unstructured":"Cairns, R. A., Harris, I. S. & Mak, T. W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85\u201395 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"115_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J. & Chandel, N. S. Fundamentals of cancer metabolism. Sci. Adv. 2, 1\u201318 (2016).","journal-title":"Sci. Adv."},{"key":"115_CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.15430\/JCP.2016.21.4.209","volume":"21","author":"J-Y Cha","year":"2017","unstructured":"Cha, J.-Y. & Lee, H.-J. Targeting lipid metabolic reprogramming as anticancer therapeutics. J. Cancer Prev. 21, 209\u2013215 (2017).","journal-title":"J. Cancer Prev."},{"key":"115_CR4","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1200\/JCO.18.00498","volume":"36","author":"C Gisselbrecht","year":"2018","unstructured":"Gisselbrecht, C. Positron emission tomography \u2013 Guided therapy of aggressive non-Hodgkin lymphoma: Standard of care after the PETAL study? J. Clin. Oncol. 36, 3272\u20133273 (2018).","journal-title":"J. Clin. Oncol."},{"key":"115_CR5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccr.2012.08.014","volume":"22","author":"P Caro","year":"2012","unstructured":"Caro, P. et al. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B-cell lymphoma. Cancer Cell 22, 547\u2013560 (2012).","journal-title":"Cancer Cell"},{"key":"115_CR6","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/nm.4399","volume":"23","author":"EM Kuntz","year":"2017","unstructured":"Kuntz, E. M. et al. Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells. Nat. Med. 23, 1234\u20131240 (2017).","journal-title":"Nat. Med."},{"key":"115_CR7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ccell.2018.10.012","volume":"34","author":"B Nachmias","year":"2018","unstructured":"Nachmias, B. & Schimmer, A. D. Metabolic flexibility in Leukemia\u2014adapt or die. Cancer Cell 34, 695\u2013696 (2018).","journal-title":"Cancer Cell"},{"key":"115_CR8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcdb.2015.09.008","volume":"43","author":"O Olivares","year":"2015","unstructured":"Olivares, O., D\u00e4britz, J. H. M., King, A., Gottlieb, E. & Halsey, C. Research into cancer metabolomics: towards a clinical metamorphosis. Semin. Cell Dev. Biol. 43, 52\u201364 (2015).","journal-title":"Semin. Cell Dev. Biol."},{"key":"115_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/bjh.14411","volume":"176","author":"L Frishman-Levy","year":"2017","unstructured":"Frishman-Levy, L. & Izraeli, S. Advances in understanding the pathogenesis of CNS acute lymphoblastic leukaemia and potential for therapy. Br. J. Haematol. 176, 157\u2013167 (2017).","journal-title":"Br. J. Haematol."},{"key":"115_CR10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(08)70070-6","volume":"9","author":"CH Pui","year":"2008","unstructured":"Pui, C. H. & Howard, S. C. Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol. 9, 257\u2013268 (2008).","journal-title":"Lancet Oncol."},{"key":"115_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-4-42","volume":"4","author":"C Halsey","year":"2011","unstructured":"Halsey, C. et al. The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; Results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI. J. Hematol. Oncol. 4, 1\u201312 (2011).","journal-title":"J. Hematol. Oncol."},{"key":"115_CR12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1182\/blood-2015-02-627414","volume":"126","author":"NS Iyer","year":"2015","unstructured":"Iyer, N. S., Balsamo, L. M., Bracken, M. B. & Kadan-Lottick, N. S. Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: a review and meta-analysis. Blood 126, 346\u2013353 (2015).","journal-title":"Blood"},{"key":"115_CR13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/1097-0142(197303)31:3<520::AID-CNCR2820310306>3.0.CO;2-2","volume":"31","author":"RA Price","year":"1973","unstructured":"Price, R. A. & Johnson, W. W. The central nervous system in childhood leukemia: I. The arachnoid. Cancer 31, 520\u2013533 (1973).","journal-title":"Cancer"},{"key":"115_CR14","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1182\/blood-2015-08-665034","volume":"127","author":"MTS Williams","year":"2016","unstructured":"Williams, M. T. S. et al. The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts. Blood 127, 1998\u20132006 (2016).","journal-title":"Blood"},{"key":"115_CR15","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.3324\/haematol.2017.174987","volume":"103","author":"J Bartram","year":"2018","unstructured":"Bartram, J. et al. High throughput sequencing in acute lymphoblastic leukemia reveals clonal architecture of central nervous system and bone marrow compartments. Haematologica 103, e110\u2013e114 (2018).","journal-title":"Haematologica"},{"key":"115_CR16","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1182\/blood-2016-06-721712","volume":"129","author":"I Kato","year":"2017","unstructured":"Kato, I. et al. Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGFA. Blood 129, 3126\u20133129 (2017).","journal-title":"Blood"},{"key":"115_CR17","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/nature08020","volume":"459","author":"S Buonamici","year":"2009","unstructured":"Buonamici, S. et al. CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature 459, 1000\u20131004 (2009).","journal-title":"Nature"},{"key":"115_CR18","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2014-06-583062","volume":"125","author":"S Krause","year":"2015","unstructured":"Krause, S. et al. Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS). Blood 125, 820\u2013830 (2015).","journal-title":"Blood"},{"key":"115_CR19","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1200\/JCO.2007.11.8166","volume":"25","author":"G Cario","year":"2007","unstructured":"Cario, G. et al. High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS. J. Clin. Oncol. 25, 4813\u20134820 (2007).","journal-title":"J. Clin. Oncol."},{"key":"115_CR20","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1182\/blood-2013-05-499970","volume":"123","author":"MTS Williams","year":"2014","unstructured":"Williams, M. T. S. et al. Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemia. Blood 123, 3116\u20133127 (2014).","journal-title":"Blood"},{"key":"115_CR21","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2014-08-595108","volume":"125","author":"L Frishman-Levy","year":"2015","unstructured":"Frishman-Levy, L. et al. Central nervous system acute lymphoblastic leukemia: role of natural killer cells. Blood 125, 3420\u20133431 (2015).","journal-title":"Blood"},{"key":"115_CR22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood-2017-03-769315","volume":"130","author":"V M\u00fcnch","year":"2017","unstructured":"M\u00fcnch, V. et al. Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor. Blood 130, 643\u2013654 (2017).","journal-title":"Blood"},{"key":"115_CR23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.expneurol.2015.07.027","volume":"273","author":"R Spector","year":"2015","unstructured":"Spector, R., Robert Snodgrass, S. & Johanson, C. E. A balanced view of the cerebrospinal fluid composition and functions: focus on adult humans. Exp. Neurol. 273, 57\u201368 (2015).","journal-title":"Exp. Neurol."},{"key":"115_CR24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1155\/2006\/158797","volume":"22","author":"AF H\u00fchmer","year":"2006","unstructured":"H\u00fchmer, A. F., Biringer, R. G., Amato, H., Fonteh, A. N. & Harrington, M. G. Protein analysis in human cerebrospinal fluid: physiological aspects, current progress and future challenges. Dis. Markers 22, 3\u201326 (2006).","journal-title":"Dis. Markers"},{"key":"115_CR25","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1152\/physrev.00004.2013","volume":"93","author":"HH Damkier","year":"2013","unstructured":"Damkier, H. H., Brown, P. D. & Praetorius, J. Cerebrospinal fluid secretion by the choroid plexus. Physiol. Rev. 93, 1847\u20131892 (2013).","journal-title":"Physiol. Rev."},{"key":"115_CR26","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S M\u00e9ndez-Ferrer","year":"2010","unstructured":"M\u00e9ndez-Ferrer, S. et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829\u2013834 (2010).","journal-title":"Nature"},{"key":"115_CR27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12984","volume":"505","author":"SJ Morrison","year":"2014","unstructured":"Morrison, S. J. & Scadden, D. T. The bone marrow niche for haematopoietic stem cells. Nature 505, 327\u2013334 (2014).","journal-title":"Nature"},{"key":"115_CR28","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1158\/0008-5472.CAN-13-2645","volume":"74","author":"SWZ Olechnowicz","year":"2014","unstructured":"Olechnowicz, S. W. Z. & Edwards, C. M. Contributions of the host microenvironment to cancer-induced bone disease. Cancer Res. 74, 1625\u20131631 (2014).","journal-title":"Cancer Res."},{"key":"115_CR29","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood.V114.22.1630.1630","volume":"114","author":"EM Eckhoff","year":"2009","unstructured":"Eckhoff, E. M., Queudeville, M., Debatin, K.-M. & Meyer, L. H. A novel B cell precursor ALL cell line (018Z) with prominent neurotropism and isolated CNS leukemia in a NOD\/SCID\/huALL xenotransplantation model. Blood 114, 1630\u20131630 (2009).","journal-title":"Blood"},{"key":"115_CR30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/bjh.13887","volume":"172","author":"VHJ van der Velden","year":"2016","unstructured":"van der Velden, V. H. J. et al. New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemia. Br. J. Haematol. 172, 769\u2013781 (2016).","journal-title":"Br. J. Haematol."},{"key":"115_CR31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nchembio.2016","volume":"12","author":"PC Theodoropoulos","year":"2016","unstructured":"Theodoropoulos, P. C. et al. Discovery of tumor-specific irreversible inhibitors of stearoyl-CoA desaturase. Nat. Chem. Biol. 12, 218\u2013225 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"115_CR32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature10602","volume":"481","author":"CM Metallo","year":"2012","unstructured":"Metallo, C. M. et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481, 380\u2013384 (2012).","journal-title":"Nature"},{"key":"115_CR33","doi-asserted-by":"crossref","first-page":"24364","DOI":"10.18632\/oncotarget.25273","volume":"9","author":"C Angelucci","year":"2018","unstructured":"Angelucci, C. et al. Pivotal role of human stearoyl-CoA desaturases (SCD1 and 5) in breast cancer progression: oleic acid-based effect of SCD1 on cell migration and a novel pro-cell survival role for SCD5. Oncotarget 9, 24364\u201324380 (2018).","journal-title":"Oncotarget"},{"key":"115_CR34","doi-asserted-by":"crossref","first-page":"e11394","DOI":"10.1371\/journal.pone.0011394","volume":"5","author":"D Hess","year":"2010","unstructured":"Hess, D., Chisholm, J. W. & Igal, R. A. Inhibition of stearoyl-CoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLoS ONE 5, e11394 (2010).","journal-title":"PLoS ONE"},{"key":"115_CR35","doi-asserted-by":"crossref","first-page":"e0166231","DOI":"10.1371\/journal.pone.0166231","volume":"11","author":"J Wang","year":"2016","unstructured":"Wang, J. et al. High expression of stearoyl-CoA desaturase 1 predicts poor prognosis in patients with clear-cell renal cell carcinoma. PLoS ONE 11, e0166231 (2016).","journal-title":"PLoS ONE"},{"key":"115_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0001-8","volume":"6","author":"L Chen","year":"2016","unstructured":"Chen, L. et al. Stearoyl-CoA desaturase-1-mediated cell apoptosis in colorectal cancer by promoting ceramide synthesis. Sci. Rep. 6, 1\u201311 (2016).","journal-title":"Sci. Rep."},{"key":"115_CR37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10059-011-0043-5","volume":"31","author":"SJ Kim","year":"2011","unstructured":"Kim, S. J., Choi, H., Park, S. S., Chang, C. & Kim, E. Stearoyl-CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation. Mol. Cells 31, 371\u2013377 (2011).","journal-title":"Mol. Cells"},{"key":"115_CR38","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1128\/MCB.05672-11","volume":"32","author":"H Zhang","year":"2012","unstructured":"Zhang, H., Li, H., Ho, N., Li, D. & Li, S. Scd1 plays a tumor-suppressive role in survival of leukemia stem cells and the development of chronic myeloid leukemia. Mol. Cell Biol. 32, 1776\u20131787 (2012).","journal-title":"Mol. Cell Biol."},{"key":"115_CR39","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1158\/0008-5472.CAN-15-0202","volume":"75","author":"AD Southam","year":"2015","unstructured":"Southam, A. D. et al. Drug redeployment to kill leukemia and lymphoma cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids. Cancer Res. 75, 2530\u20132540 (2015).","journal-title":"Cancer Res."},{"key":"115_CR40","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1016\/j.bmc.2017.05.016","volume":"25","author":"K Imamura","year":"2017","unstructured":"Imamura, K. et al. Discovery of novel and potent stearoyl coenzyme a desaturase 1 (SCD1) inhibitors as anticancer agents. Bioorganic Med. Chem. 25, 3768\u20133779 (2017).","journal-title":"Bioorganic Med. Chem."},{"key":"115_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/msb.2011.51","volume":"7","author":"O Folger","year":"2011","unstructured":"Folger, O. et al. Predicting selective drug targets in cancer through metabolic networks. Mol. Syst. Biol. 7, 1\u201310 (2011).","journal-title":"Mol. Syst. Biol."},{"key":"115_CR42","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1093\/jn\/131.9.2260","volume":"131","author":"M Miyazaki","year":"2001","unstructured":"Miyazaki, M., Man, W. C. & Ntambi, J. M. Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid. J. Nutr. 131, 2260\u20132268 (2001).","journal-title":"J. Nutr."},{"key":"115_CR43","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/MOL.0b013e32833854ac","volume":"21","author":"JM Brown","year":"2010","unstructured":"Brown, J. M. & Rudel, L. L. Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery. Curr. Opin. Lipidol. 21, 192\u2013197 (2010).","journal-title":"Curr. Opin. Lipidol."},{"key":"115_CR44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/leu.2017.294","volume":"32","author":"C Prieto","year":"2018","unstructured":"Prieto, C. et al. NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL. Leukemia 32, 633\u2013644 (2018).","journal-title":"Leukemia"},{"key":"115_CR45","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1200\/JCO.19.00261","volume":"37","author":"R Pieters","year":"2019","unstructured":"Pieters, R. et al. Outcome of infants younger than 1 year with acute lymphoblastic leukemia treated with the interfant-06 protocol: results from an international phase III randomized study. J. Clin. Oncol. 37, 2246\u20132256 (2019).","journal-title":"J. Clin. Oncol."},{"key":"115_CR46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41586-019-0904-1","volume":"566","author":"K Vriens","year":"2019","unstructured":"Vriens, K. et al. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity. Nature 566, 403\u2013406 (2019).","journal-title":"Nature"},{"key":"115_CR47","doi-asserted-by":"crossref","first-page":"e0181243","DOI":"10.1371\/journal.pone.0181243","volume":"12","author":"A Ono","year":"2017","unstructured":"Ono, A. et al. Feedback activation of AMPK-mediated autophagy acceleration is a key resistance mechanism against SCD1 inhibitor-induced cell growth inhibition. PLoS ONE 12, e0181243 (2017).","journal-title":"PLoS ONE"},{"key":"115_CR48","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1182\/blood-2007-04-082040","volume":"110","author":"N Hagedorn","year":"2007","unstructured":"Hagedorn, N. et al. Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of \u201cisolated\u201d and its possible clinical implications, a collaborative study of the Resistant Disease Committee. Blood 110, 4022\u20134029 (2007).","journal-title":"Blood"},{"key":"115_CR49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cmet.2011.12.015","volume":"15","author":"MO Yuneva","year":"2012","unstructured":"Yuneva, M. O. et al. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab. 15, 157\u2013170 (2012).","journal-title":"Cell Metab."},{"key":"115_CR50","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","volume":"164","author":"CT Hensley","year":"2016","unstructured":"Hensley, C. T. et al. Metabolic heterogeneity in human lung tumors. Cell 164, 681\u2013694 (2016).","journal-title":"Cell"},{"key":"115_CR51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature16967","volume":"531","author":"EM Kerr","year":"2016","unstructured":"Kerr, E. M., Gaude, E., Turrell, F. K., Frezza, C. & Martins, C. P. Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities. Nature 531, 110\u2013113 (2016).","journal-title":"Nature"},{"key":"115_CR52","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/febs.14090","volume":"284","author":"M Sciacovelli","year":"2017","unstructured":"Sciacovelli, M. & Frezza, C. Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer. FEBS J. 284, 3132\u20133144 (2017).","journal-title":"FEBS J."},{"key":"115_CR53","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12625","volume":"501","author":"RA Burrell","year":"2013","unstructured":"Burrell, R. A., McGranahan, N., Bartek, J. & Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501, 338\u2013345 (2013).","journal-title":"Nature"},{"key":"115_CR54","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"115_CR55","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/hum.2008.188","volume":"20","author":"A Ibrahimi","year":"2009","unstructured":"Ibrahimi, A. et al. Highly efficient multicistronic lentiviral vectors with peptide 2A sequences. Hum. Gene Ther. 20, 845\u2013860 (2009).","journal-title":"Hum. Gene Ther."},{"key":"115_CR56","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0009-9120(83)90676-8","volume":"16","author":"ST Agnese","year":"1983","unstructured":"Agnese, S. T., Spierto, F. W. & Hannon, W. H. Evaluation of four reagents for delipidation of serum. Clin. Biochem. 16, 98\u2013100 (1983).","journal-title":"Clin. Biochem."},{"key":"115_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11306-016-0994-9","volume":"12","author":"S Tumanov","year":"2016","unstructured":"Tumanov, S. et al. Calibration curve-free GC\u2013MS method for quantitation of amino and non-amino organic acids in biological samples. Metabolomics 12, 1\u201313 (2016).","journal-title":"Metabolomics"},{"key":"115_CR58","doi-asserted-by":"crossref","unstructured":"Mackay, G. M., Niels, L. Z., Broek, J. F. van den & Gottlieb, E. in Metabolic Analysis Using Stable Isotopes (ed., Metallo, C. M.) 171\u2013196 (Elsevier, 2015).","DOI":"10.1016\/bs.mie.2015.05.016"},{"key":"115_CR59","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3, 1101\u20131108 (2008).","journal-title":"Nat. Protoc."},{"key":"115_CR60","doi-asserted-by":"crossref","unstructured":"Martin, M. & N, T. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17, 10\u201312 (2011).","DOI":"10.14806\/ej.17.1.200"},{"key":"115_CR61","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525\u2013527 (2016).","journal-title":"Nat. Biotechnol."},{"key":"115_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2014-15-1-r1","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 1\u201321 (2014).","journal-title":"Genome Biol."},{"key":"115_CR63","unstructured":"Warnes, G. R. et al. gplots: Various R programming tools for plotting data. R package v.3.0-1. http:\/\/CRAN.R-project.org\/package=gplots (2015)."}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-00115-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-00115-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-00115-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T04:48:44Z","timestamp":1670388524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-020-00115-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,28]]},"references-count":63,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["115"],"URL":"https:\/\/doi.org\/10.1038\/s43018-020-00115-2","relation":{},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,28]]},"assertion":[{"value":"28 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.G. is a board member and a shareholder of Metabomed Ltd., Israel, J.J.K. is an employee and shareholder of Rheos Medicines Inc. M.G.K. is a consultant for Accent Therapeutics and M.G.K.\u2019s laboratory receives some financial support from 28-7. These disclosures are not directly related to these studies. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}